Published on 23 May 2023 on Investing.com
The Rising Challenge for Intercept Pharmaceuticals: Analyst Downgrade Amid Ocaliva's DILI Concerns...
Canaccord Genuity has lowered the price target for Intercept Pharmaceutical Inc (NASDAQ: ICPT) from...
NASDAQ.ICPT price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free